1.Nielsen SM，Rhodes L，Blanco I，et al. Von Hippel-Lindau Disease：Genetics and Role of Genetic Counseling in a Multiple Neoplasia Syndrome. J Clin Oncol，2016，34（18）：2172-2181.

2.Moreira DM，Gershman B，Lohse CM，et al. Paraneoplastic syndromes are associated with adverse prognosis among patients with renal cell carcinoma undergoing nephrectomy. World J Urol. 2016；34（10）：1465-1472.

3.Hegemann M，Kroeger N，Stenzl A，et al. Rare and changeable as a chameleon：paraneoplastic syndromes in renal cell carcinoma. World J Urol，2018，36（6）：849-854.

4.Sacco E，Pinto F，Sasso F，et al. Paraneoplastic syndromes in patients with urological malignancies. Urol Int，2009.83（1）：1-11.

5.Kim HL，Belldegrun AS，Freitas DG，et al. Paraneoplastic signs and symptoms of renal cell carcinoma：implications for prognosis. J Urol，2003，170（5）：1742-1746.

6.Srigley JR，Delahunt B，Eble JN，et al. The International Society of Urological Pathology（ISUP）Vancouver Classification of Renal Neoplasia. Am J Surg Pathol，2013，37（10）：1469-1489.

7.Neuzillet Y，Tillou X，Mathieu R.，et al. Renal cell carcinoma（RCC）in patients with end-stage renal disease exhibits many favourable clinical，pathologic，and outcome features compared with RCC in the general population. Eur Urol，2011，60（2）：366-373.